Asamli, Kaiser U.
HRN: 21-47-76 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/30/2022
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/30/2022
07/06/2022
IV
1.5gms
Q6hrs
Empiric
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes